blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3307781

EP3307781 - ANTIBODIES, COMPOUNDS AND SCREENS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.09.2021
Database last updated on 30.10.2024
FormerThe patent has been granted
Status updated on  25.09.2020
FormerGrant of patent is intended
Status updated on  14.05.2020
FormerExamination is in progress
Status updated on  07.12.2018
FormerRequest for examination was made
Status updated on  16.03.2018
FormerThe international publication has been made
Status updated on  16.12.2016
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
The Broad Institute, Inc.
415 Main Street
Cambridge, MA 02142 / US
For all designated states
Dana-Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, MA 02215 / US
[2020/45]
Former [2019/37]For all designated states
The Broad Institute, Inc.
415 Main Street
Cambridge, MA 02142 / US
For all designated states
Dana-Farber Cancer Institute Inc. et Al.
450 Brookline Avenue
Boston, MA 02215 / US
Former [2018/16]For all designated states
The Broad Institute Inc.
415 Main Street
Cambridge, MA 02142 / US
For all designated states
Dana-Farber Cancer Institute Inc. et Al.
450 Brookline Avenue
Boston, MA 02215 / US
Inventor(s)01 / THOMAS, David, K.
7A Colchester Street
Brookline, MA 02446 / US
02 / GOLUB, Todd, R.
65 Waldorf Road
Newtown, MA 02464 / US
 [2018/16]
Representative(s)Plasseraud IP
104 Rue de Richelieu
CS92104
75080 Paris Cedex 02 / FR
[N/P]
Former [2020/44]Plasseraud IP
66, rue de la Chaussée d'Antin
75440 Paris Cedex 09 / FR
Former [2018/16]Cabinet Plasseraud
66, rue de la Chaussée d'Antin
75440 Paris Cedex 09 / FR
Application number, filing date16733251.910.06.2016
[2018/16]
WO2016US37082
Priority number, dateUS201562173901P10.06.2015         Original published format: US 201562173901 P
US201562173908P10.06.2015         Original published format: US 201562173908 P
US201562182140P19.06.2015         Original published format: US 201562182140 P
US201562193516P16.07.2015         Original published format: US 201562193516 P
[2018/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016201368
Date:15.12.2016
Language:EN
[2016/50]
Type: A1 Application with search report 
No.:EP3307781
Date:18.04.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 15.12.2016 takes the place of the publication of the European patent application.
[2018/16]
Type: B1 Patent specification 
No.:EP3307781
Date:28.10.2020
Language:EN
[2020/44]
Type: B8 Corrected title page of specification 
No.:EP3307781
Date:02.12.2020
[2020/49]
Search report(s)International search report - published on:EP15.12.2016
ClassificationIPC:A61K31/166, A61K31/426, A61P43/00, C07K16/28, G01N33/68
[2020/16]
CPC:
C07K16/2803 (EP,US); A61K31/166 (EP,US); A61K31/4164 (US);
A61K31/426 (EP,US); A61P43/00 (EP,US); G01N33/5023 (US);
G01N33/6893 (EP,US); A61K38/16 (US); C07K2317/33 (EP,US);
C07K2317/34 (EP,US); C07K2317/76 (EP,US); G01N2800/042 (EP,US);
G01N2800/10 (EP,US); G01N2800/122 (EP,US); G01N2800/32 (EP,US);
G01N2800/52 (EP,US) (-)
Former IPC [2018/16]C07K16/28, C07D233/64, C07C233/65, G01N33/68, G01N33/50, A61K31/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/16]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ANTIKÖRPER, VERBINDUNGEN UND TESTS ZUR IDENTIFIZIERUNG UND BEHANDLUNG VON KACHEXIE ODER PRÄKACHEXIE[2018/16]
English:ANTIBODIES, COMPOUNDS AND SCREENS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA[2018/16]
French:ANTICORPS, COMPOSÉS ET ÉCRANS PERMETTANT L'IDENTIFICATION ET LE TRAITEMENT LA CACHEXIE OU PRÉ-CACHEXIE[2018/16]
Entry into regional phase10.01.2018National basic fee paid 
10.01.2018Designation fee(s) paid 
10.01.2018Examination fee paid 
Examination procedure10.01.2018Examination requested  [2018/16]
10.01.2018Date on which the examining division has become responsible
22.08.2018Amendment by applicant (claims and/or description)
05.12.2018Despatch of a communication from the examining division (Time limit: M04)
09.04.2019Reply to a communication from the examining division
09.08.2019Despatch of a communication from the examining division (Time limit: M04)
10.12.2019Reply to a communication from the examining division
15.05.2020Communication of intention to grant the patent
15.09.2020Fee for grant paid
15.09.2020Fee for publishing/printing paid
15.09.2020Receipt of the translation of the claim(s)
30.09.2020Request for correction of the decision to grant filed
Divisional application(s)EP20196326.1  / EP3822291
Opposition(s)29.07.2021No opposition filed within time limit [2021/40]
Fees paidRenewal fee
27.06.2018Renewal fee patent year 03
27.06.2019Renewal fee patent year 04
29.06.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.06.2016
AL28.10.2020
AT28.10.2020
CY28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
MK28.10.2020
MT28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
IE10.06.2021
LU10.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
[2024/42]
Former [2024/22]HU10.06.2016
AL28.10.2020
AT28.10.2020
CY28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
MK28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
IE10.06.2021
LU10.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2023/33]HU10.06.2016
AL28.10.2020
AT28.10.2020
CY28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
IE10.06.2021
LU10.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2023/30]AL28.10.2020
AT28.10.2020
CY28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
IE10.06.2021
LU10.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/34]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
IE10.06.2021
LU10.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/23]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
IE10.06.2021
LU10.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/21]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
PT01.03.2021
IE10.06.2021
LU10.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/18]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
PT01.03.2021
LU10.06.2021
Former [2022/10]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
PT01.03.2021
Former [2022/08]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
MC28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/50]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SI28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/48]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
IT28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/45]AL28.10.2020
AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/37]AT28.10.2020
CZ28.10.2020
DK28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/36]AT28.10.2020
CZ28.10.2020
EE28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/35]AT28.10.2020
CZ28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RO28.10.2020
RS28.10.2020
SE28.10.2020
SK28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/34]AT28.10.2020
CZ28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RS28.10.2020
SE28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/33]AT28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LT28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RS28.10.2020
SE28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/32]AT28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RS28.10.2020
SE28.10.2020
SM28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/30]AT28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LV28.10.2020
NL28.10.2020
PL28.10.2020
RS28.10.2020
SE28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/28]AT28.10.2020
ES28.10.2020
FI28.10.2020
HR28.10.2020
LV28.10.2020
PL28.10.2020
RS28.10.2020
SE28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/25]AT28.10.2020
ES28.10.2020
FI28.10.2020
LV28.10.2020
PL28.10.2020
RS28.10.2020
SE28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
IS28.02.2021
PT01.03.2021
Former [2021/23]AT28.10.2020
FI28.10.2020
LV28.10.2020
RS28.10.2020
SE28.10.2020
BG28.01.2021
NO28.01.2021
GR29.01.2021
PT01.03.2021
Former [2021/22]FI28.10.2020
RS28.10.2020
NO28.01.2021
PT01.03.2021
Former [2021/21]FI28.10.2020
PT01.03.2021
Former [2021/20]FI28.10.2020
Cited inInternational search[XA]WO2007109747  (WYETH CORP [US], et al);
 [A]WO2010019656  (WYETH CORP [US], et al);
 [XA]WO2011042548  (SANOFI AVENTIS [FR], et al);
 [XP]WO2015085097  (BROAD INST INC [US], et al);
by applicantUS5030015
 US5846946
 WO0204113
 US2004013648
 WO2004016229
 US7067554
 US2006281180
 US2007025970
 US2007054961
 WO2007089616
 US7259015
 WO2007109747
 WO2007109749
 US7303910
 US7329684
 US7351585
 WO2008137552
 US2009007284
 US2009017543
 US7485697
 US2009035302
 US2009111106
 WO2009136382
 WO2010019656
 US7714013
 US7737285
 US7776919
 US2010226915
 US2010317109
 WO2011042548
 WO2011053707
 US2011117189
 US7981424
 US2011293571
 US2012295960
 US8404658
 US8420083
 US8454972
 US8580833
 US9045461
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.